ArticleTranslational cancer research2025

Integrative analysis of polo-like kinase family identifies a prognostic signature and validates PLK2 as a therapeutic target in glioma.

Chengjun Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.